Pharmacological thiamine levels as a therapeutic approach in Alzheimer's disease
Graphical AbstractSummary of the study.
Main Authors: | Gary E. Gibson, Howard H. Feldman, Sheng Zhang, Sarah A. Flowers, José A. Luchsinger |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2022.1033272/full |
Similar Items
-
Thiamine and benfotiamine: Focus on their therapeutic potential
by: Iva Bozic, et al.
Published: (2023-11-01) -
Serum Metabolomic and Lipidomic Profiling Reveals Novel Biomarkers of Efficacy for Benfotiamine in Alzheimer’s Disease
by: Ruchika Bhawal, et al.
Published: (2021-12-01) -
Chemoreactomic analysis of thiamine disulfide, thiamine hydrochloride, and benfotiamine molecules
by: O. A. Gromova, et al.
Published: (2017-07-01) -
Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Benfotiamine in Healthy Subjects
by: Sheng L, et al.
Published: (2021-03-01) -
The Role of AGE-RAGE Signalling as a Modulator of Gut Permeability in Diabetes
by: Matthew Snelson, et al.
Published: (2022-02-01)